Novo Nordisk shares fell by 23.11% at the closing of the stock market today, marking the largest single-day drop in the company’s history. The decline follows the company’s decision to lower its ...

Novo Nordisk has named Maziar Mike Doustdar as its new president and chief executive officer. He will take over the role on 7 August 2025, replacing Lars Fruergaard Jørgensen, who will step down the ...